Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Starmann, Julia ^a   Fälth, Maria ^a,b   Spindelböck, Walter ^c   Lanz, Katja Lauren ^c   Lackner, Carolin ^c   Zatloukal, Kurt ^c   Trauner, Michael ^c,d   Sültmann, Holger ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b GLAXOSMITHKLINE   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER RESECTION; MALE; NONALCOHOLIC FATTY LIVER; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STEATOSIS; UPREGULATION;

ADULT; AGED; ALDEHYDE REDUCTASE; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; KERATINS, TYPE I; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84867366175     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046584     Document Type: Article

References (39)

1. Angulo P, (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
2. Cohen JC, Horton JD, Hobbs HH, (2011) Human fatty liver disease: old questions and new insights. Science 332: 1519-1523.
3. Lazo M, Clark JM, (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28: 339-350.
4. Trauner M, Arrese M, Wagner M, (2010) Fatty liver and lipotoxicity. Biochim Biophys Acta 1801: 299-310.
5. Machado M, Marques-Vidal P, Cortez-Pinto H, (2006) Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 45: 600-606.
6. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, et al. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140: 124-131.
7. Syn WK, Teaberry V, Choi SS, Diehl AM, (2009) Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis 29: 200-210.
8. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
9. Cossrow N, Falkner B, (2004) Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 89: 2590-2594.
10. Day CP, James OF, (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
11. Neuschwander-Tetri BA, Caldwell SH, (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219.
12. Yip WW, Burt AD, (2006) Alcoholic liver disease. Semin Diagn Pathol 23: 149-160.
13. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
14. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
15. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
16. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
17. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
18. Brunt EM (2006) Non-alcoholic fatty liver disease. In: Burt AD, Portmann BC, Ferrell LD, editors. MacSween's Pathology of the Liver. Philadelphia: Churchill Livingstone. pp. 367-397.
19. Alexa A, Rahnenfuhrer J, Lengauer T, (2006) Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22: 1600-1607.
20. Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, et al. (2005) Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 25: 760-771.
21. Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, et al. (2010) Hepatic Gene Expression of Caucasian and African-American Patients with Obesity-Related Non-Alcoholic Fatty Liver Disease. Obes Surg 20 (5): 640-650.
22. Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, et al. (2009) Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44 (Suppl 19):: 89-95.
23. Cao D, Fan ST, Chung SS, (1998) Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem 273: 11429-11435.
24. Scuric Z, Stain SC, Anderson WF, Hwang JJ, (1998) New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology 27: 943-950.
25. Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, et al. (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res 11: 1776-1785.
26. Yoshitake H, Takahashi M, Ishikawa H, Nojima M, Iwanari H, et al. (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int J Gynecol Cancer 17: 1300-1306.
27. Penning TM, (2005) AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin Cancer Res 11: 1687-1690.
28. Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, et al. (2010) Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. J Hepatol 52: 220-227.
29. Wang C, Yan R, Luo D, Watabe K, Liao DF, et al. (2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem 284: 26742-26748.
30. Ma J, Yan R, Zu X, Cheng JM, Rao K, et al. (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem 283: 3418-3423.
31. Martin HJ, Maser E, (2009) Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. Chem Biol Interact 178: 145-150.
32. Mattson MP, (2009) Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 44: 625-633.
33. Neuschwander-Tetri BA, (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52: 774-788.
34. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-1465.
35. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA, (2010) Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 42: 21-23.
36. Birkenkamp-Demtroder K, Mansilla F, Sorensen FB, Kruhoffer M, Cabezon T, et al. (2007) Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro. Mol Oncol 1: 181-195.
37. Wang K, Xu X, Nie Y, Dai L, Wang P, et al. (2009) Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma. Cancer Lett 281: 144-150.
38. Stumptner C, Heid H, Fuchsbichler A, Hauser H, Mischinger HJ, et al. (1999) Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. Am J Pathol 154: 1701-1710.
39. Stumptner C, Fuchsbichler A, Zatloukal K, Denk H, (2007) In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62. Hepatology 46: 851-860.